VSEE HEALTH, INC. Annual Report - How They Did This Year

I’ve put together this guide to help you understand VSee Health’s performance. My goal is to break down their filings into simple terms so you can decide if this company fits your investment goals.

1. The Big Picture

VSee Health acts as the "digital plumbing" for virtual healthcare. Their business has two main sides:

• VSee Lab: They sell "no-code" software building blocks. Think of this as a digital Lego set that lets hospitals build custom telehealth apps without hiring expensive programmers.
• iDoc: This is their service arm. They provide specialized doctors—like radiologists and neurologists—to hospital ICUs and prisons remotely. They earn money through service contracts with healthcare systems and government agencies.

2. The Money Talk

The company is currently losing money. In 2024, they brought in about $17.8 million in revenue. They lost $9.6 million in 2025, an improvement from their $62.2 million loss in 2024. That massive 2024 loss came from one-time costs related to their transition to a public company. Despite this improvement, they have a total deficit of over $82 million. They expect to keep spending more than they make because their operating costs continue to outpace their sales.

3. Financial Health: The "Going Concern" Warning

This is the most critical part of the report. Management has stated there is "substantial doubt" about their ability to stay in business for the next 12 months. They have about $1.2 million in cash, which isn't enough to cover their daily operating costs. They don't have a clear path to profit. If they can't borrow more money or find new investors, they may not be able to keep the lights on. Any future fundraising will likely involve issuing more shares, which reduces your ownership percentage and could lower the value of your investment.

4. What Could Go Wrong

Beyond the cash shortage, the company faces serious hurdles:

• Internal Control Issues: They admitted to "material weaknesses" in their accounting. Simply put, their system for tracking money isn't reliable. This increases the risk of financial errors.
• Regulatory Minefield: They must follow strict rules from the FDA, FTC, and FCC, plus HIPAA privacy laws. If they fail to comply, they face massive fines or could be shut down.
• The Competition: They fight against giants like Teladoc and Amwell. If VSee can’t prove their software is better or cheaper, these well-funded competitors could push them out of the market.
• No R&D Budget: Because they are short on cash, they have stopped spending on research and development. This makes it hard to keep up with competitors who are adding AI and new tools to their platforms.

5. The Team

VSee employs about 209 people, including 93 doctors. Leadership is currently focused on the transition to a public company, which has diverted time and money away from product innovation.

6. Looking Ahead

The company is betting that a national doctor shortage will force hospitals to use their remote staffing. However, their success depends on hospitals actually choosing their platform, which is not guaranteed. They must increase their provider count and secure long-term contracts to survive.

Note: Given the "going concern" warning and accounting issues, this is a high-risk situation. Before investing, consider whether you are comfortable with a company that is currently struggling to fund its own daily operations.